News
The single-tier test uses artificial intelligence to accurately detect Lyme disease from the first few weeks of infection ...
Freenome, a biotechnology company pioneering an early cancer detection platform, today announced an exclusive license agreement with Exact Sciences to advance the commercialization of its colorectal ...
WTVR Richmond, VA on MSN4h
New blood test could detect 10 types of cancer with a single screeningA groundbreaking blood test being studied in Virginia could detect 10 different types of cancer with a single screening, ...
A heartwarming Instagram video shows how a service dog accompanies his owner to a blood test. Named Waso, he seems to go ...
A blood test being studied in Virginia could detect 10 different types of cancer with a single screening, potentially transforming early detection and treatment outcomes.
The blood test, and others like it, have been gaining momentum among doctors who use them to help detect cancers that ...
A silent killer, heart attack, claims lives in India, often without warning. Advances in cardiovascular diagnostics offer ...
Despite the indication of a potential risk, people who receive abnormal results on blood-based colorectal screening tests commonly do not receive the follow-up colonoscopy.
A major Alzheimer’s disease medical group is recommending that specialists may use certain blood tests to help diagnose ...
Just under half of patients receiving an abnormal blood-based colorectal cancer screening test result receive a follow-up ...
The test looks for certain proteins in the blood which show the immune system is responding to the first signs of cancer ...
Exact Sciences is paying $75 million for exclusive rights to a blood-based "liquid biopsy" screening test from rival firm Freenome ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results